Pacific Biosciences Of California (PACB) Capital Expenditures (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Capital Expenditures of $3.0 million for Q1 2026, up 119.08% year-over-year from $1.4 million in Q1 2025, and up 253.43% quarter-over-quarter from $861000.0 in Q4 2025.
Pacific Biosciences Of California (PACB) Capital Expenditures (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Capital Expenditures history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 119.08% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $4.4 million (up 18.12% YoY), while the FY2025 annual figure was $2.7 million, down 56.14% from the prior year.
- Capital Expenditures for Q1 2026 stood at $3.0 million, up from $861000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $4.9 million in Q4 2022, with the low at -$787000.0 in Q3 2024.
- The 5-year median for Capital Expenditures is $2.0 million (2023), against an average of $2.2 million.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures soared 807.23% in 2022, then slumped 194.82% in 2024.
- Pacific Biosciences Of California's Capital Expenditures stood at $4.9 million in 2022, then sank by 58.73% to $2.0 million in 2023, then retreated by 20.11% to $1.6 million in 2024, then sank by 46.75% to $861000.0 in 2025, then surged by 253.43% to $3.0 million in 2026.
- Business Quant data shows PACB's Capital Expenditures at $3.0 million in Q1 2026, $861000.0 in Q4 2025, and -$86000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Pacific Biosciences Of California | 398.57 Mn | 161.70 Mn | 12.64 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Mn |
| Jun 30, 2026 | 1.56 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 861,000.00 |
| Dec 31, 2025 | 861,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | 550,000.00 |
| Jun 30, 2025 | 550,000.00 |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | -787,000.00 |
| Sep 30, 2024 | -787,000.00 |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Mar 31, 2024 | 3.88 Mn |